Skip to content
Sexuality – Lifestyle
Author:
Transpire Bio
TranspireBio Announces Successful Completion of a Pivotal Phase 1 Study with its Proprietary Springboard™ Soft Mist Inhaler Platform
October 6, 2026
Transpire Bio to Participate in Upcoming Healthcare Investor Conferences During September
September 2, 2026
Transpire Bio’s Dr. Lei Mao Appointed as Board Chair of the IPAC-RS for its 2026-2028 Term
August 11, 2026
Transpire Bio to Present at the 2026 BIO International Convention
June 18, 2026
Transpire Bio’s ANDA for Generic High-Strength Trelegy® Ellipta® Accepted for Filing by the U.S. FDA
May 11, 2026
Transpire Bio Announces Opening of New Satellite R&D Facility in Shanghai, China
April 28, 2026